ENGENE HOLDINGS INC (ENGN) Stock Price, Quote, News and Overview
NASDAQ:ENGN - Nasdaq - CA29286M1059 - Common Stock - Currency: USD
ENGN Quote, Performance and Key Statistics
NASDAQ:ENGN (7/15/2025, 11:31:22 AM)
3.46
+0.12 (+3.59%)
The current stock price of ENGN is 3.46 USD. In the past month the price increased by 2.77%. In the past year, price decreased by -62.85%.
ENGN Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 18.03 | 327.05B | ||
| AMGN | AMGEN INC | 14.08 | 157.18B | ||
| GILD | GILEAD SCIENCES INC | 14.06 | 135.36B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | N/A | 121.47B | ||
| REGN | REGENERON PHARMACEUTICALS | 12.51 | 59.86B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 40.70B | ||
| ARGX | ARGENX SE - ADR | 97.09 | 34.09B | ||
| ONC | BEONE MEDICINES LTD-ADR | 6.79 | 28.78B | ||
| BNTX | BIONTECH SE-ADR | N/A | 26.28B | ||
| NTRA | NATERA INC | N/A | 20.83B | ||
| INSM | INSMED INC | N/A | 19.40B | ||
| BIIB | BIOGEN INC | 8.23 | 19.08B |
Related stock screener links
About ENGN
Company Profile
enGene Holdings, Inc. is a clinical-stage biotechnology company, which engages in developing gene therapies. The company is headquartered in Saint-Laurent, Quebec and currently employs 56 full-time employees. The company went IPO on 2021-12-10. The Company’s lead program is detalimogene voraplasmid, (detalimogene) for patients with non-muscle invasive bladder cancer (NMIBC), a disease with a high clinical burden. Detalimogene is being evaluated in the ongoing multi-cohort LEGEND Phase II study, which includes a cohort studying detalimogene in Bacillus Calmette-Guerin (BCG)-unresponsive patients with carcinoma in situ (Cis). Detalimogene is being developed through its proprietary Dually Derivatized Oligochitosan (DDX) platform, which enables penetration of mucosal tissues and delivery of a wide range of sizes and types of cargo, including DNA and various forms of RNA. The firm is developing non-viral genetic medicines based on its DDX gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.
Company Info
ENGENE HOLDINGS INC
4868 Rue Levy, Suite 220
Saint-Laurent QUEBEC CA
Employees: 56
Phone: 15143324888
ENGENE HOLDINGS INC / ENGN FAQ
What is the stock price of ENGENE HOLDINGS INC today?
The current stock price of ENGN is 3.46 USD. The price increased by 3.59% in the last trading session.
What is the ticker symbol for ENGENE HOLDINGS INC stock?
The exchange symbol of ENGENE HOLDINGS INC is ENGN and it is listed on the Nasdaq exchange.
On which exchange is ENGN stock listed?
ENGN stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for ENGENE HOLDINGS INC stock?
17 analysts have analysed ENGN and the average price target is 22.9 USD. This implies a price increase of 561.96% is expected in the next year compared to the current price of 3.46. Check the ENGENE HOLDINGS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is ENGENE HOLDINGS INC worth?
ENGENE HOLDINGS INC (ENGN) has a market capitalization of 176.84M USD. This makes ENGN a Micro Cap stock.
How many employees does ENGENE HOLDINGS INC have?
ENGENE HOLDINGS INC (ENGN) currently has 56 employees.
What are the support and resistance levels for ENGENE HOLDINGS INC (ENGN) stock?
ENGENE HOLDINGS INC (ENGN) has a support level at 3.28 and a resistance level at 3.66. Check the full technical report for a detailed analysis of ENGN support and resistance levels.
Should I buy ENGENE HOLDINGS INC (ENGN) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of ENGN, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of ENGN, evaluating the profitability, health, valuation and growth aspects
- ENGENE HOLDINGS INC (ENGN) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- ENGENE HOLDINGS INC (ENGN) Sales and EPS estimates to see what analysts future expectations are.
- ENGENE HOLDINGS INC (ENGN) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- ENGENE HOLDINGS INC (ENGN) Insider and Institutional Ownership to learn about the owners and their transactions.
- ENGENE HOLDINGS INC (ENGN) Stock Chart to make your own analysis
- ENGENE HOLDINGS INC (ENGN) Latest news and press-releases to stay up to date.
Does ENGENE HOLDINGS INC (ENGN) stock pay dividends?
ENGN does not pay a dividend.
When does ENGENE HOLDINGS INC (ENGN) report earnings?
ENGENE HOLDINGS INC (ENGN) will report earnings on 2025-09-11.
What is the Price/Earnings (PE) ratio of ENGENE HOLDINGS INC (ENGN)?
ENGENE HOLDINGS INC (ENGN) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.65).
ENGN Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to ENGN. When comparing the yearly performance of all stocks, ENGN is a bad performer in the overall market: 96.08% of all stocks are doing better.
ENGN Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to ENGN. While ENGN seems to be doing ok healthwise, there are quite some concerns on its profitability.
ENGN Financial Highlights
Over the last trailing twelve months ENGN reported a non-GAAP Earnings per Share(EPS) of -1.65. The EPS decreased by -56.01% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -29.96% | ||
| ROE | -35.14% | ||
| Debt/Equity | 0.09 |
ENGN Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 85% to ENGN. The Buy consensus is the average rating of analysts ratings from 17 analysts.